UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems

Pharmacological reviews, 2016-04, Vol.68 (2), p.419-457

2016

Volltextzugriff (PDF)

NOP receptor pharmacological profile - A dynamic mass redistribution study

PloS one, 2018-08, Vol.13 (8), p.e0203021-e0203021

2018

Volltextzugriff (PDF)

NOP-Targeted Peptide Ligands

The Nociceptin/Orphanin FQ Peptide Receptor, 2019-01, Vol.254, p.17-36

2019

Volltextzugriff (PDF)

NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine

Psychopharmacology, 2018-11, Vol.235 (11), p.3093-3102

2018

Volltextzugriff (PDF)

Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor

Peptides (New York, N.Y. : 1980), 2018-03, Vol.101, p.227-233

2018

Volltextzugriff (PDF)

Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors

Molecules (Basel, Switzerland), 2019-12, Vol.24 (24), p.4460

2019

Volltextzugriff (PDF)

Corrigendum to “Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor” [Peptides 101 (2018) 227–233]

Peptides (New York, N.Y. : 1980), 2023-07, Vol.165, p.171012-171012, Article 171012

2023

Volltextzugriff (PDF)

Pharmacological Assays for Investigating the NOP Receptor

Handbook of experimental pharmacology, 2019-01, Vol.254, p.69-89

2019

Volltextzugriff (PDF)

Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs

Pharmacology & therapeutics (Oxford), 2013-10, Vol.140 (1), p.10-25

2013

Volltextzugriff (PDF)

Chimeric G proteins in fluorimetric calcium assays: experience with opioid receptors

Methods in molecular biology (Clifton, N.J.), 2013, Vol.937, p.293

2013

Volltextzugriff (PDF)

Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors

Peptides (New York, N.Y. : 1980), 2018-01, Vol.99, p.195-204

2018

Volltextzugriff (PDF)

Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test

Behavioural brain research, 2019-01, Vol.356, p.120-126

2019

Volltextzugriff (PDF)

In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant

Peptides (New York, N.Y. : 1980), 2012-09, Vol.37 (1), p.86-97

2012

Volltextzugriff (PDF)

In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH 2 , a mu opioid receptor agonist biased toward β-arrestin

Peptides (New York, N.Y. : 1980), 2018-07, Vol.105, p.51-57

2018

Volltextzugriff (PDF)

Functional selectivity of EM-2 analogs at the mu-opioid receptor

Frontiers in pharmacology, 2023-02, Vol.14, p.1133961-1133961

2023

Volltextzugriff (PDF)

A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ

Bioorganic & medicinal chemistry, 2014-07, Vol.22 (14), p.3703-3712

2014

Volltextzugriff (PDF)

In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl

Neuropharmacology, 2022-05, Vol.209, p.109020-109020, Article 109020

2022

Volltextzugriff (PDF)

In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH2, a mu opioid receptor agonist biased toward β-arrestin

Peptides (New York, N.Y. : 1980), 2018-07, Vol.105, p.51-57

2018

Volltextzugriff (PDF)

Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)

European journal of pharmacology, 2017-01, Vol.794, p.115-126

2017

Volltextzugriff (PDF)

Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor

Medicinal research reviews, 2010-09, Vol.30 (5), p.751-777

2010

Volltextzugriff (PDF)

Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling

Psychopharmacology, 2024-05, Vol.241 (5), p.1001-1010

2024

Volltextzugriff (PDF)

Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies

Neuropharmacology, 2011-03, Vol.60 (4), p.572-579

2011

Volltextzugriff (PDF)

Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation

Neuropharmacology, 2017-10, Vol.125, p.39-49

2017

Volltextzugriff (PDF)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands

Frontiers in pharmacology, 2022-04, Vol.13, p.873082-873082

2022

Volltextzugriff (PDF)

Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness

Psychopharmacology, 2016-07, Vol.233 (13), p.2525-2532

2016

Volltextzugriff (PDF)

1 – 25 von 379

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(338)

Publikationsform

Sprache

Englisch
(379)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems

NOP receptor pharmacological profile - A dynamic mass redistribution study

NOP-Targeted Peptide Ligands

NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine

Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor

Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors

Corrigendum to “Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor” [Peptides 101 (2018) 227–233]

Pharmacological Assays for Investigating the NOP Receptor

Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs

Chimeric G proteins in fluorimetric calcium assays: experience with opioid receptors

Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors

Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test

In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant

In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH 2 , a mu opioid receptor agonist biased toward β-arrestin

Functional selectivity of EM-2 analogs at the mu-opioid receptor

A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ

In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl

In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH2, a mu opioid receptor agonist biased toward β-arrestin

Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)

Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor

Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling

Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies

Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands

Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness

Suchergebnisse filtern